Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA)

NCT ID: NCT05900778

Last Updated: 2023-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-10

Study Completion Date

2028-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Using a randomized controlled trial design, in an hospital environment, possible changes induced by the "Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)" treatment program will be investigated in functional activities of daily living, motor and cognitive assessment of children with acquired brain injury.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim is to investigate, for the first time, the effectiveness of HABIT-ILE therapy in a hospital setting in the treatment of a population representative of the clinical population with children with acquired brain injuries.

The hypothesis is that an in-hospital HABIT-ILE protocol will be more effective than conventional therapies usually given to children with acquired brain injury, and that this difference will be objectively demonstrated by clinical assessments of motor function, cognition and participation conducted before and after treatment periods.

The aim of the study is therefore to evaluate the effect of intensive bimanual hand-arm therapy including the lower extremities (HABIT-ILE) on body functions and structures, activity and participation in children with acquired brain injury.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acquired Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HABIT-ILE

Hand and arm bimanuel intensive therapy including lowers extremities

Group Type EXPERIMENTAL

HABIT-ILE

Intervention Type BEHAVIORAL

2 weeks HABIT-ILE

Conventional intervention

Conventional physical and occupational therapy

Group Type ACTIVE_COMPARATOR

Conventional intervention

Intervention Type BEHAVIORAL

2 weeks usual intervention (waitlist group)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HABIT-ILE

2 weeks HABIT-ILE

Intervention Type BEHAVIORAL

Conventional intervention

2 weeks usual intervention (waitlist group)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children with acquired brain injury of school
* age 5 to 18 years inclusive

Exclusion Criteria

* Unstable seizure
* programmed botulinum toxin or orthopedic surgery in the 6 months previous to the intervention, during intervention period or 3months after the intervention time
* Severe visual or cognitive impairments likely to interfere with intervention or testing session completion
Minimum Eligible Age

5 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yannick Bleyenheuft

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yannick Bleyenheuft, Professor

Role: PRINCIPAL_INVESTIGATOR

Insititue of Neurosciences, UCLouvain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Neurologique William Lennox

Ottignies-Louvain-la-Neuve, Brabant-Wallon, Belgium

Site Status RECRUITING

Institute of Neurosciences, UCLouvain

Brussels, , Belgium

Site Status RECRUITING

Spontaneous contact via doctors or other partners

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yannick Bleyenheuft, Professor

Role: CONTACT

+32 2 764 93 49

Julie Paradis, Doctor

Role: CONTACT

+32 489 28 12 50

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anne Klocker, PhD

Role: primary

Yannick Bleyenheuft, Professor

Role: primary

+32 2 764 93 49

Julie Paradis

Role: backup

+32 489 28 12 50

anne Klocker, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B0392023000044

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hand and Arm Rehabilitation Using VR
NCT06373341 RECRUITING NA